Common Contracts
5 similar Executive Employment Agreement contracts by Threshold Pharmaceuticals Inc
EX-10.45 19 d384597dex1045.htm EX-10.45 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 5th, 2020 • New Jersey
This First Amendment to Executive Employment Agreement (this “Amendment), dated as of November 19, 2014 (the “Effective Date”), is entered into by and between Molecular Templates, Inc. a Delaware corporation (the “Company”), and David Valacer (“Executive”).
MOLECULAR TEMPLATES, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 15th, 2017 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • Texas
THIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of April 22, 2016 (the “Effective Date”) by and between Molecular Templates, Inc., a Delaware corporation (the “Company”), and Jason Kim (“Executive”).
MOLECULAR TEMPLATES, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 15th, 2017 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • Texas
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of April 8th, 2016 (the “Effective Date”) by and between Molecular Templates, Inc., a Delaware corporation (the “Company”), and Kurt Elster (“Executive”).
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 15th, 2017 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
This First Amendment to Executive Employment Agreement (this “Amendment), dated as of November 19, 2014 (the “Effective Date”), is entered into by and between Molecular Templates, Inc. a Delaware corporation (the “Company”), and David Valacer (“Executive”).
MOLECULAR TEMPLATES, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 15th, 2017 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • Texas
THIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of April 22, 2016 (the “Effective Date”) by and between Molecular Templates, Inc., a Delaware corporation (the “Company”), and Eric Poma (“Executive”).
